Access the latest news about Vidium and veterinary cancer diagnostics while exploring upcoming conferences and event information.
October 13-15, 2022; Norfolk, VA
Join us to view posters “Mutation landscape and clinical actionability in canine melanoma” by Vidium expert Dr. Esther Chon, and “Development and Validation Procedures for Improving SearchLight DNA, a Canine Cancer Genomic Diagnostic Panel” by Vidium’s bioinformatician Manisha Warrier.
October 14, 2022, 8am EST; Norfolk, VA
Join Dr. Esther Chon in panel discussion “Options & Evidence: Novel Diagnostics Panel Discussion”
June 23-25, 2022; Austin, TX
Join us to hear talks presented by Vidium experts Dr. Guannan Wang, Dr. Esther Chon and Dr. Derick Whitley
January 15–19, 2022; Orlando, FL
Come visit us at Booth # 930
If you would like to meet with our team while at the conference or discuss a case: SCHEDULE A MEETING
March 6-9, 2022; Las Vegas, NV
If you would like to meet with our team while at the conference or discuss a case: SCHEDULE A MEETING
April 9-12, 2022; Puerto Vallarta, Mexico
If you would like to meet with our team while at the conference or discuss a case: SCHEDULE A MEETING
Vidium Animal Health® announced today that it has partnered with Torigen Pharmaceuticals, an animal health biologics company, to…
Vidium Animal Health® announced today that it has entered a reseller agreement with Antech Diagnostics® to…
Torigen Pharmaceuticals, Inc, a commercial-stage animal health biologics company, today announced it has…
Vidium Animal Health® announced that it has added specialty pathology services to its in-house genomic and molecular diagnostic testing capabilities and has…
Vidium Animal Health announced that it is presenting virtually at the Biotech Showcase™ 2022 conference, January 10-19…
Vidium Animal Health announced it has more than doubled the size of its management team since the company launched in …
After more than a decade of pioneering the study of naturally occurring cancer in pet dogs, the Translational Genomics …
Ethos Veterinary Health, Ethos Discovery, and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, announced today …
